GINGER FONTENOT: Open Payments
NPI 1346693785 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,399 in 136 payments from 31 companies in 2025. Trend: 2023 $439 · 2024 $2,240 · 2025 $3,399
Food & beverage: $3,399
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 19 | $348 |
| Insulet Corporation | 9 | $345 |
| BETA BIONICS, INC. | 8 | $297 |
| Amgen Inc. | 15 | $295 |
| Tandem Diabetes Care, Inc. | 11 | $263 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $191 |
| UCB, Inc. | 8 | $184 |
| Corcept Therapeutics | 5 | $178 |
| Abbott Laboratories | 3 | $165 |
| Sequel Med Tech, LLC | 4 | $139 |
Products named: Dexcom G6 Transmitter, Omnipod, iLet Bionic Pancreas, t:slim X2 Insulin Pump with Control-IQ, Bimzelx, Korlym, FREESTYLE LIBRE 3, EVENITY.
Industry payments across LA — which companies pay providers there.
